DiaMedica Therapeutics Inc. (DMAC): Price and Financial Metrics
DMAC Price/Volume Stats
| Current price | $4.14 | 52-week high | $6.82 |
| Prev. close | $4.09 | 52-week low | $2.14 |
| Day low | $4.02 | Volume | 124,000 |
| Day high | $4.33 | Avg. volume | 93,254 |
| 50-day MA | $3.93 | Dividend yield | N/A |
| 200-day MA | $4.74 | Market Cap | 177.54M |
DMAC Stock Price Chart Interactive Chart >
DiaMedica Therapeutics Inc. (DMAC) Company Bio
DiaMedica Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of novel recombinant proteins. It offers DM199 product which focuses on acute ischemic stroke (AIS), and chronic kidney disease (CKD). The company was founded by Wayne Lautt on January 21, 2000 and is headquartered in Minneapolis, MN.
DMAC Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
DMAC Price Returns
| 1-mo | 12.20% |
| 3-mo | -28.25% |
| 6-mo | -22.33% |
| 1-year | 61.72% |
| 3-year | 66.27% |
| 5-year | -11.54% |
| YTD | -23.76% |
| 2024 | 91.20% |
| 2023 | 79.74% |
| 2022 | -57.64% |
| 2021 | -63.21% |
| 2020 | 109.07% |